Lululemon Athletica (NASDAQ: LULU) has lost 40% of its value this year, with disappointing earnings and a troubling forecast continuing to weigh heavily on investor confidence.

The company reported first-quarter revenue of $2.5 billion for the period ending May 3, representing a 4% year-over-year increase, or just 2% on a constant-dollar basis.

While the top-line figure edged out the consensus estimate of $2.43 billion, the results were far from what investors have historically expected from one of retail’s premier growth stories.

Lululemon cut its full-year earnings guidance alongside the first-quarter report, sending the stock down an additional 11% in after-hours trading on top of its already steep year-to-date decline.

The company’s second-quarter forecast also came in well below analyst expectations, adding further pressure to a stock that has struggled to find a floor in recent months.

A familiar pattern continued inside the results, with comparable sales falling 5% in the Americas while international markets posted a robust 13% increase in comparable sales.

Gross margin declined 410 basis points to 54.2%, with 280 basis points of that decline attributed directly to the negative impact of tariffs, while the remainder stemmed from fixed cost deleverage tied to weak North American comparable sales.

New CEO Heidi O’Neill, who brings decades of experience from Nike, now faces the formidable task of reversing the brand’s declining momentum in its core North American market.

O’Neill’s strong pedigree offers some optimism, but analysts and investors broadly agree that executing a meaningful turnaround in a difficult consumer environment will take considerable time and effort.

For investors weighing whether the stock represents an opportunity at current levels, the central question is whether Lululemon’s international growth and leadership transition can offset persistent weakness at home.

The athleisure brand, once regarded as a reliable growth stock, now presents a markedly different risk profile, with compressed margins, softening North American demand, and an uncertain near-term earnings trajectory.

Unless investors carry a high tolerance for risk and significant patience, the stock remains a precarious bet, as cheap valuations alone offer no guarantee against further downside in the quarters ahead.